Fall 2021 | Boston, MA
Dr. Bhhatarai joined Novartis (NIBR) since Nov 2015 to support computational ADME projects using machine learning, data integration, ADME modeling and MedChem based approaches. Before, Novartis, he was a System Toxicology Informatics fellow in the Predictive Safety Assessment Center at The Dow Chemical Company, Michigan, where he contributed to the development, assessment and implementation of novel in-silico approaches aimed at predicting potential mammalian and environmental health effects. He did post-doctoral research focusing on cheminformatics, bio-assay/ chemical ontology and computer-aided drug design at Center for Computational Science at University of Miami, Florida. After obtaining his PhD from Clarkson University, New York in Dec 2007, he joined the University of Insubria, Varese, Italy where he performed Predictive Toxicology research and Risk Assessment of emerging pollutants for an EU-FP7 project – CADASTER. He is a member of the American Society for Cellular and Computational Toxicology (ASCCT) and the American Chemical Society (ACS – COMP, CINF). He has authored more than 25 peer-reviewed publications and several presentations.